Filtered By:
Cancer: Leukemia
Vaccination: Varicella-Zoster Virus Vaccine

This page shows you your search results in order of date.

Order by Relevance | Date

Total 12 results found since Jan 2013.

Epidemiology of Herpes Zoster in the pre-vaccination era: establishing the baseline for vaccination programme's impact in Spain
ConclusionOf all patients hospitalised with HZ, those with greater risk of mortality or readmission belonged to the groups prioritised by the current vaccination recommendations of the Spanish Ministry of Health. Our study provided relevant information on clinical aspects of HZ and established the base for future assessments of vaccination policies.PMID:36820639 | PMC:PMC9951257 | DOI:10.2807/1560-7917.ES.2023.28.8.2200390
Source: Euro Surveill - February 23, 2023 Category: Infectious Diseases Authors: Carlos Risco Risco Zaida Herrador Noem í Lopez-Parea Diego Mart ínez-Urbistondo Rafael Su árez Del Villar Carrero Josefa Masa-Calles Source Type: research

Safety of mRNA COVID-19 Vaccines in Patients with Inborn Errors of Immunity: an Italian Multicentric Study
CONCLUSION: Although our follow-up period is relatively short, the safety data we reported are reassuring. This data would help to contrast the vaccine hesitancy often manifested by patients with IEI and to better inform their healthcare providers.PMID:36374363 | DOI:10.1007/s10875-022-01402-6
Source: Herpes - November 14, 2022 Category: Infectious Diseases Authors: Cinzia Milito Francesco Cinetto Giulia Garzi Andrea Palladino Marco Puca Elena Brambilla Camilla De Vitis Giulia Costanzo Riccardo Scarpa Alessandra Punziano Gianluca Lagnese Stefano Del Giacco Giuseppe Spadaro Isabella Quinti Davide Firinu Source Type: research

Vaccination efficacy in patients with chronic lymphocytic leukemia
Leuk Lymphoma. 2022 Oct 21:1-15. doi: 10.1080/10428194.2022.2133538. Online ahead of print.ABSTRACTChronic lymphocytic leukemia (CLL) is a disorder of mature malignant B cells with multiple elements of immune dysfunction. Infections are common in CLL patients due to complex immunodeficiency. Vaccines are used as preventative measures for common diseases including influenza, pneumococcus, tetanus/diphtheria and shingles in the general population. Vaccines are utilized to mitigate this risk, although there have been some concerns regarding the efficacy of vaccines in the CLL population due to the inherent complex immune dysf...
Source: Herpes - October 21, 2022 Category: Infectious Diseases Authors: Kevin Y Wang Pratik Shah Brandon Skavla Fatima Fayaaz Jeffrey Chi Joanna M Rhodes Source Type: research

Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus
Ann Hematol. 2022 Jan 7. doi: 10.1007/s00277-021-04746-y. Online ahead of print.ABSTRACTClinical reactivations of herpes simplex virus or varicella zoster virus occur frequently among patients with malignancies and manifest particularly as herpes simplex stomatitis in patients with acute leukaemia treated with intensive chemotherapy and as herpes zoster in patients with lymphoma or multiple myeloma. In recent years, knowledge on reactivation rates and clinical manifestations has increased for conventional chemotherapeutics as well as for many new antineoplastic agents. This guideline summarizes current evidence on herpesvi...
Source: Herpes - January 7, 2022 Category: Infectious Diseases Authors: Larissa Henze Christoph Buhl Michael Sandherr Oliver A Cornely Werner J Heinz Yascha Khodamoradi Til Ramon Kiderlen Philipp Koehler Alrun Seidler Rosanne Sprute Martin Schmidt-Hieber Marie von Lilienfeld-Toal Source Type: research